X
CAD
$1000,395,000
CannTrust
BOUGHT DEAL, JUNE 2018
Mergers & Acquisition Advisory
Enabling strategic transactions
The mergers and acquisitions advisory capability at Bloom Burton guides clients to conceptualize, structure and execute transactions to maximize returns and company performance.
Our team’s professional expertise in healthcare and intellectual property also allows us to guide our clients with scientific and technical due diligence on their M&A opportunities and development strategies.
Guiding a broad range of M&A-type transactions
- Strategic Acquisitions
- Sales & Divestitures
- Spinoffs & Splitoffs
- Strategic Partnerships
- Reorganization & Restructuring
- Leveraged Buyouts
- Takeover Defenses and Proxy Contests
- Special Committee Assignments
- Fairness/Valuation Opinions
RECENT ISSUES AND FINANCING
adMare BioInnovations
Precision Nutrition
Nuvo Pharmaceuticals Inc.
Med BioGene Inc.
Bradmer Pharmaceuticals Inc.
Medicure Inc.
YM Biosciences Inc.
Conjuchem LLC
Patient Home Monitoring Corp.
Miraculins Inc.
Advitech Inc.
Stellar Pharmaceuticals Inc.
Pharmagap Inc.
YM BioSciences Inc.
Victhom Human Bionics Inc.
Thallion Pharmaceuticals Inc.
Bioniche Life Sciences Inc.
Noden Pharma Inc.
Response Biomedical Corp.
Red Leaf Medical Inc.
LED Medical Diagnostics Inc.
Hamilton Thorne Ltd.
Alveda Pharmaceuticals Inc.
Medical Futures Inc.
Canadian Public Biotech Company
Tribute Pharmaceuticals Canada Inc.
CRH Medical Corporation
